RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
106 hedge funds and large institutions have $287M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 18 closing their positions.
39% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 18
19% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 32
6% more funds holding
Funds holding: 100 → 106 (+6)
17% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $22.1M
57% less capital invested
Capital invested by funds: $673M → $287M (-$386M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
Tourbillon Capital Partners
New York
|
+$18.4M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$16.4M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$8.1M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.31M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$6.34M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$6.03M |
| 3 |
TA
Teachers Advisors
New York
|
-$4.3M |
| 4 |
PA
Perceptive Advisors
New York
|
-$4.17M |
| 5 |
Jane Street
New York
|
-$2.55M |
RPTP Hedge Fund Activity: Q3 2015 in Review
106 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q3 2015, worth a combined $287M — down 57% from $673M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new RPTP positions and 18 closed out — a net gain of 7 holders — while 38 added to existing stakes and 32 trimmed.
The largest buyer was Tourbillon Capital Partners, opening a new position worth an estimated $18.4M. The largest seller was Guggenheim Capital, exiting entirely with an estimated $6.34M sold.
- 106 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q3 2015, up from 100 in Q2 2015.
- Funds reported $287M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q3 2015, down 57% quarter-over-quarter.
- 25 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q3 2015 and 18 closed out, a net change of +7 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q3 2015 was Tourbillon Capital Partners, an estimated $18.4M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q3 2015 was Guggenheim Capital, an estimated $6.34M sold.
Based on aggregated 13F filings for Q3 2015.